|
1
|
Ciangola CI, Capuano I, Perrone F and
Franceschilli L: Epidemiology and Prevalence of Pelvic Floor
DisordersPelvic Floor Disorders: Surgical Approach. Gaspari AL and
Sileri P: Springer Milan; Milano: pp. 9–15. 2014, View Article : Google Scholar
|
|
2
|
Dietz HP: Prolapse worsens with age,
doesn't it? Aust N Z J Obstet Gynaecol. 48:587–591. 2008.
View Article : Google Scholar : PubMed/NCBI
|
|
3
|
Neimark M: Genital Prolapse, Urogenital
Atrophy, and Sexual DysfunctionPelvic Floor Dysfunction: A
Multidisciplinary Approach. Davila GW, Ghoniem GM and Wexner SD:
Springer London; London: pp. 19–23. 2009, View Article : Google Scholar
|
|
4
|
Swift SE, Pound T and Dias JK:
Case-control study of etiologic factors in the development of
severe pelvic organ prolapse. Int Urogynecol J Pelvic Floor
Dysfunct. 12:187–192. 2001. View Article : Google Scholar : PubMed/NCBI
|
|
5
|
Lien KC, Mooney B, DeLancey JOL and
Ashton-Miller JA: Levator ani muscle stretch induced by simulated
vaginal birth. Obstet Gynecol. 103:31–40. 2004. View Article : Google Scholar : PubMed/NCBI
|
|
6
|
Handa VL, Lockhart ME, Fielding JR,
Bradley CS, Brubaker L, Cundiff GW, Ye W and Richter HE: Pelvic
Floor Disorders Network: Racial differences in pelvic anatomy by
magnetic resonance imaging. Obstet Gynecol. 111:914–920. 2008.
View Article : Google Scholar : PubMed/NCBI
|
|
7
|
Jack GS, Nikolova G, Vilain E, Raz S and
Rodríguez LV: Familial transmission of genitovaginal prolapse. Int
Urogynecol J Pelvic Floor Dysfunct. 17:498–501. 2006. View Article : Google Scholar : PubMed/NCBI
|
|
8
|
SpenceJones C, Kamm MA, Henry MM and
Hudson CN: Bowel dysfunction: A pathogenic factor in uterovaginal
prolapse and urinary stress incontinence. Br J Obstet Gynaecol.
101:147–152. 1994. View Article : Google Scholar : PubMed/NCBI
|
|
9
|
Sileri P, Franceschilli L, Cadeddu F, De
Luca E, D'Ugo S, Tognoni V, Camperchioli I, Benavoli D, Di Lorenzo
N, Gaspari AL, et al: Prevalence of defaecatory disorders in
morbidly obese patients before and after bariatric surgery. J
Gastrointest Surg. 16:62–66; discussion 66-67. 2012. View Article : Google Scholar : PubMed/NCBI
|
|
10
|
Liapis A, Bakas P, Pafiti A,
FrangosPlemenos M, Arnoyannaki N and Creatsas G: Changes of
collagen type III in female patients with genuine stress
incontinence and pelvic floor prolapse. Eur J Obstet Gynecol Reprod
Biol. 97:76–79. 2001. View Article : Google Scholar : PubMed/NCBI
|
|
11
|
Xu P, Meng Q, Sun H, Yin Q, Yu H, Zhang Z,
Cao M, Zhang Y and Li Y: Shrapnel nanoparticles loading docetaxel
inhibit metastasis and growth of breast cancer. Biomaterials.
64:10–20. 2015. View Article : Google Scholar : PubMed/NCBI
|
|
12
|
Fang J, Xiao L, Joo KI, Liu Y, Zhang C,
Liu S, Conti PS, Li Z and Wang P: A potent immunotoxin targeting
fibroblast activation protein for treatment of breast cancer in
mice. Int J Cancer. 138:1013–1023. 2015. View Article : Google Scholar : PubMed/NCBI
|
|
13
|
Chu Y, Tang H, Guo Y, Guo J, Huang B, Fang
F, Cai J and Wang Z: Adipose-derived mesenchymal stem cells promote
cell proliferation and invasion of epithelial ovarian cancer. Exp
Cell Res. 337:16–27. 2015. View Article : Google Scholar : PubMed/NCBI
|
|
14
|
Zhang Q, Guo Y, Dong R, Dai R and Zhou M:
Suppressor of cytokine signaling 1-modulated metalloproteinases and
tissue inhibitor of metalloproteinase in pulmonary fibrosis. Mol
Med Rep. 12:3855–3861. 2015.PubMed/NCBI
|
|
15
|
Curry TE Jr and Osteen KG: Cyclic changes
in the matrix metalloproteinase system in the ovary and uterus.
Biol Reprod. 64:1285–1296. 2001. View Article : Google Scholar : PubMed/NCBI
|
|
16
|
Quinones S, Buttice G and Kurkinen M:
Promoter elements in the transcriptional activation of the human
stromelysin-1 gene by the inflammatory cytokine, interleukin 1.
Biochem J. 302:471–477. 1994. View Article : Google Scholar : PubMed/NCBI
|
|
17
|
Murphy G, Cockett MI, Stephens PE, Smith
BJ and Docherty AJ: Stromelysin is an activator of procollagenase.
A study with natural and recombinant enzymes. Biochem J.
248:265–268. 1987. View Article : Google Scholar : PubMed/NCBI
|
|
18
|
Tepliakov AT, Berezikova EN, Shilov SN,
Grakova EV, Torim II, Efremov AV, Safronov ID, Pustovetova MG and
Karpov RS: Assessment of the role of matrix metalloproteinase-3
gene polymorphism in the development of chronic heart failure. Ter
Arkh. 87:8–12. 2015.(In Russian). View Article : Google Scholar : PubMed/NCBI
|
|
19
|
Zhang C, Chen L and Gu Y: Polymorphisms of
MMP-1 and MMP-3 and susceptibility to rheumatoid arthritis. A
meta-analysis. Z Rheumatol. 74:258–262. 2015. View Article : Google Scholar : PubMed/NCBI
|
|
20
|
Davis FM, Rateri DL and Daugherty A:
Abdominal aortic aneurysm: Novel mechanisms and therapies. Curr
Opin Cardiol. 30:566–573. 2015. View Article : Google Scholar : PubMed/NCBI
|
|
21
|
Ferrari MM, Rossi G, Biondi ML, Viganò P,
Dell'utri C and Meschia M: Type I collagen and matrix
metalloproteinase 1, 3 and 9 gene polymorphisms in the
predisposition to pelvic organ prolapse. Arch Gynecol Obstet.
285:1581–1586. 2012. View Article : Google Scholar : PubMed/NCBI
|
|
22
|
Marín-García J: Molecular Genetics of
Coronary Artery Disease and Myocardial InfarctionPost-Genomic
Cardiology. 2nd edition. Elsevier; Amsterdam: pp. 217–250. 2014,
View Article : Google Scholar
|
|
23
|
Skorupski P, Miotła P, Jankiewicz K and
Rechberger T: MMP-1 and MMP-3 gene encoding polymorphism and the
risk of the development of pelvic organ prolapse and stress urinary
incontinence. Ginekol Pol. 81:594–599. 2010.(In Polish). PubMed/NCBI
|
|
24
|
Skorupski P, Jankiewicz K, Miotła P,
Marczak M, Kulik-Rechberger B and Rechberger T: The polymorphisms
of the MMP-1 and the MMP-3 genes and the risk of pelvic organ
prolapse. Int Urogynecol J Pelvic Floor Dysfunct. 24:1033–1038.
2013. View Article : Google Scholar
|
|
25
|
Thiagamoorthy G, Zacchè M, Cardozo L,
Naidu M, Giarenis I, Flint R, Srikrishna S and Robinson D: Digital
assessment and quantification of pelvic organ prolapse (DPOP-Q): A
randomised cross-over diagnostic agreement trial. Int Urogynecol J
Pelvic Floor Dysfunct. 27:433–437. 2016. View Article : Google Scholar
|
|
26
|
Petrie A and Sabin C: Medical statistics
at a glance. 3rd edition. John Wiley & Sons, Inc.; Hoboken, NJ:
2013
|
|
27
|
Biancheri P, Brezski RJ, Di Sabatino A,
Greenplate AR, Soring KL, Corazza GR, Kok KB, Rovedatti L,
Vossenkämper A, Ahmad N, et al: Proteolytic cleavage and loss of
function of biologic agents that neutralize tumor necrosis factor
in the mucosa of patients with inflammatory bowel disease.
Gastroenterology. 149:1564–1574.e3. 2015. View Article : Google Scholar : PubMed/NCBI
|
|
28
|
Dey S, Stalin S, Gupta A, Saha D, Kesh K
and Swarnakar S: Matrix Metalloproteinase-3 gene promoter
polymorphisms and their haplotypes are associated with gastric
cancer risk in eastern Indian population. Mol Carcinog. 51(Suppl
1): E42–E53. 2012. View
Article : Google Scholar : PubMed/NCBI
|
|
29
|
Waples RS: Testing for Hardy-Weinberg
proportions: Have we lost the plot? J Hered. 106:1–19. 2015.
View Article : Google Scholar : PubMed/NCBI
|
|
30
|
Vlaykova T, Kurzawski M, Tacheva T, Dimov
D, Gulubova M, Yovchev Y, Chakarov S and Drozdzik M: Investigation
of the role of MMP3 −1171insA polymorphism in cutaneous malignant
melanoma - a preliminary study. Biotechnol Biotechnol Equip.
28:904–910. 2014. View Article : Google Scholar : PubMed/NCBI
|
|
31
|
Fröhlich E: Proteases in cutaneous
malignant melanoma: Relevance as biomarker and therapeutic target.
Cell Mol Life Sci. 67:3947–3960. 2010. View Article : Google Scholar : PubMed/NCBI
|
|
32
|
Goncalves I, Bengtsson E, Colhoun HM,
Shore AC, Palombo C, Natali A, Edsfeldt A, Dunér P, Fredrikson GN,
Björkbacka H, et al: SUMMIT Consortium: Elevated Plasma Levels of
MMP-12 Are Associated With Atherosclerotic Burden and Symptomatic
Cardiovascular Disease in Subjects With Type 2 Diabetes.
Arterioscler Thromb Vasc Biol. 35:1723–1731. 2015. View Article : Google Scholar : PubMed/NCBI
|
